Megace and fall Patient Reports February 12, 2012

Megace Side Effects Report #5944346-4
Megace side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2008. Female patient was diagnosed with weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: confusional state, fall , mobility decreased. Megace dosage: unknown. Patient recovered.

Megace Side Effects Report #5944554-2
Megace side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2008. Female patient was diagnosed with weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: confusional state, fall , mobility decreased. Megace dosage: unknown. Patient recovered.

Megace Side Effects Report #5574292-X
Megace side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2007. Male patient, 73 years of age, weighting 191.4 lb, was diagnosed with multiple myeloma  and was treated with Megace. After drug was administered, patient experienced the following side effects: asthenia, fall , hepatic encephalopathy, orthostatic hypotension, pyrexia, unresponsive to stimuli, vomiting. Megace dosage: 800 MG PO QD. During the same period patient was treated with ZEVALIN, VORICONAZOLE. Patient was hospitalized. Patient died on 12/22/2007.

Megace Side Effects Report #5662945-4
Megace side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2008. Female patient, weighting 93.00 lb, was diagnosed with decreased appetite and was treated with Megace. After drug was administered, patient experienced the following side effects: alopecia, fall , haemorrhage, hip fracture, vaginal haemorrhage. Megace dosage: 1 DF QD 625 MG/5 ML ORAL. During the same period patient was treated with CELEBREX, CLORAZEPATE, VITAMIN B12 NOS, METHOTREXATE, FOSAMAX, FOLIC ACID, VITAMIN CAP, CALCIUM. Patient was hospitalized. Patient recovered.


Megace Side Effects Report #5694084-0
Megace side effect was reported by a Physician from UNITED STATES on Mar 21, 2008. Male patient, weighting 138.0 lb, was diagnosed with decreased appetite and was treated with Megace. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fall , musculoskeletal chest pain, treatment noncompliance. Megace dosage: (1 DF QD 625 MG/5ML, (1 DF QD 625 MG/5 ML). During the same period patient was treated with MEGACE ES. Patient was hospitalized. Patient recovered.

Megace Side Effects Report #5738414-X
Megace side effect was reported by a Physician from UNITED STATES on Apr 30, 2008. Female patient, weighting 78.00 lb, was diagnosed with decreased appetite, weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: alopecia, blood glucose increased, fall , hip fracture, vaginal haemorrhage. Megace dosage: 1 DF QD 625 MG/5 ML ORAL. During the same period patient was treated with MEGACE ES, CELEBREX, CLORAZEPATE, VITAMIN B12 NOS, METHOTREXATE, FOSAMAX, FOLIC ACID, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Megace Side Effects Report #5490031-5
Megace side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2007. Female patient, weighting 109.0 lb, was diagnosed with cachexia, neoplasm malignant and was treated with Megace. After drug was administered, patient experienced the following side effects: balance disorder, fall , loss of consciousness, mouth ulceration, no therapeutic response, weight decreased. Megace dosage: 625 MG/5ML ORAL. During the same period patient was treated with MEGACE ES. Patient recovered.

Megace Side Effects Report #5563342-2
Megace side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Female patient, weighting 109.0 lb, was diagnosed with cachexia, neoplasm malignant and was treated with Megace. After drug was administered, patient experienced the following side effects: balance disorder, decreased appetite, fall , hypovolaemia, loss of consciousness, mouth ulceration, therapeutic agent toxicity, weight decreased. Megace dosage: 6525 MG/5ML ORAL). During the same period patient was treated with MEGACE ES. Patient recovered.